Spirulina (Arthrospira) protects against valproic acid-induced neural tube defects in mice

Resultado de la investigación: Contribución a una revistaArtículo

4 Citas (Scopus)


Valproic acid (VPA) is a potent inducer of neural tube defects in human and mouse, its teratogenicity is associated with its potential to generation of free radicals and increase oxidative stress. Furthermore, spirulina (SP) has shown pharmacological properties against teratogenicity, which are attributed to its antioxidant potential. Accordingly, the present study was performed to investigate the influence of SP on the teratogenicity of VPA in imprinting control region mice and the possible mechanisms of action. VPA (sodium valproate) was administered intraperitoneally to mice on gestation day (GD) 8 at a dose of 600 mg/kg. SP was given orally at 125, 250, and 500 mg/kg daily from GD0 through GD18. The most common finding in fetuses with VPA exposure was exencephaly. SP decreased the incidence of this and other malformations and increased levels of superoxide dismutase, catalase, and glutathione peroxidase. In conclusion, these results illustrate the protective action of SP through its antioxidant activity against VPA-induced teratogenicity. © 2012 Mary Ann Liebert, Inc. and Korean Society of Food Science and Nutrition.
Idioma originalInglés estadounidense
Páginas (desde-hasta)1103-1108
Número de páginas992
PublicaciónJournal of Medicinal Food
EstadoPublicada - 1 dic 2012

Huella Profundice en los temas de investigación de 'Spirulina (Arthrospira) protects against valproic acid-induced neural tube defects in mice'. En conjunto forman una huella única.

  • Citar esto